Pre-Op Immunotherapy May Help Treat Aggressive Breast Cancers
FRIDAY, Feb. 7, 2025 (HealthDay News) — Giving patients with a common form of breast cancer an immunotherapy drug before surgery appears to boost outcomes, a new phase 3 trial finds. The study involved patients with estrogen receptor positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancers. That’s aContinue Reading